Research progress of plant-derived natural alkaloids in central nervous system diseases

被引:9
作者
Zhang, Qingqing [1 ]
Jiang, Qinghua [2 ]
Sa, Kuiru [1 ]
Liang, Junming [1 ]
Sun, Dejuan [1 ]
Li, Hua [1 ,3 ,4 ]
Chen, Lixia [1 ,4 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang, Peoples R China
[2] China Med Univ, Shengjing Hosp, Dept Pharm, Shenyang, Peoples R China
[3] Fujian Univ Tradit Chinese Med, Coll Pharm, Fuzhou, Peoples R China
[4] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
基金
中国国家自然科学基金;
关键词
alkaloids; Alzheimer's disease; anxiety disorder; central nervous system diseases; depression; Parkinson's disease; ACETYLCHOLINESTERASE INHIBITORY-ACTIVITY; RAT HIPPOCAMPAL EXCITABILITY; ALZHEIMERS-DISEASE; TAU HYPERPHOSPHORYLATION; ACONITUM ALKALOIDS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NEUROPATHIC PAIN; AMYLOID-BETA; ANTICHOLINESTERASE ACTIVITY;
D O I
10.1002/ptr.7955
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Central nervous system (CNS) disease is one of the most important causes of human death. Because of their complex pathogenesis, more and more attention has been paid to them. At present, drug treatment of the CNS is the main means; however, most drugs only relieve symptoms, and some have certain toxicity and side effects. Natural compounds derived from plants can provide safer and more effective alternatives. Alkaloids are common nitrogenous basic organic compounds found in nature, which exist widely in many kinds of plants and have unique application value in modern medicine. For example, Galantamine and Huperzine A from medicinal plants are widely used drugs on the market to treat Alzheimer's disease. Therefore, the main purpose of this review is to provide the available information on natural alkaloids with the activity of treating central nervous system diseases in order to explore the trends and perspectives for the further study of central nervous system drugs. In this paper, 120 alkaloids with the potential effect of treating central nervous system diseases are summarized from the aspects of sources, structure types, mechanism of action and structure-activity relationship.
引用
收藏
页码:4885 / 4907
页数:23
相关论文
共 186 条
[1]   Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin [J].
Abe, Akihisa ;
Kokuba, Hiroko .
ONCOLOGY REPORTS, 2013, 29 (04) :1333-1342
[2]   Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria [J].
Achan, Jane ;
Talisuna, Ambrose O. ;
Erhart, Annette ;
Yeka, Adoke ;
Tibenderana, James K. ;
Baliraine, Frederick N. ;
Rosenthal, Philip J. ;
D'Alessandro, Umberto .
MALARIA JOURNAL, 2011, 10
[3]   Pre-clinical investigations of β-carboline alkaloids as antidepressant agents: A systematic review [J].
Alves Ferraz, Christiane Adrielly ;
de Oliveira Junior, Raimundo Goncalves ;
Picot, Laurent ;
Guedes da Silva Almeida, Jackson Roberto ;
Nunes, Xirley Pereira .
FITOTERAPIA, 2019, 137
[4]   The effects of Aconitum alkaloids on the central nervous system [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1998, 56 (02) :211-235
[5]   Structure-dependent differences in the effects of the Aconitum alkaloids lappaconitine, N-desacetyllappaconitine and lappaconidine in rat hippocampal slices [J].
Ameri, A .
BRAIN RESEARCH, 1997, 769 (01) :36-43
[6]   Inhibition of rat hippocampal excitability by the Aconitum alkaloid, 1-benzoylnapelline, but not by napelline [J].
Ameri, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) :145-152
[7]   Structure-dependent inhibitory action of the Aconitum alkaloids 14-benzoyltalitasamine and talitasamine in rat hippocampal slices [J].
Ameri, A .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (06) :585-592
[8]   Inhibition of rat hippocampal excitability by the plant alkaloid 3-acetylaconitine mediated by interaction with voltage-dependent sodium channels [J].
Ameri, A .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (02) :273-280
[9]   Implantable pumps for drug delivery to the brain [J].
Bakhshi, S ;
North, RB .
JOURNAL OF NEURO-ONCOLOGY, 1995, 26 (02) :133-139
[10]   Evidence-based pharmacological treatment of generalized anxiety disorder [J].
Baldwin, David S. ;
Waldman, Sarah ;
Allgulander, Christer .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (05) :697-710